Risk for ILD/Pneumonitis Examined for Trastuzumab Deruxtecan
Pooled analysis of data from phase I and II studies used to evaluate AE of interstitial lung disease/pneumonitis associated with T-Dxd
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.